Related Experiment Video

Updated: Aug 15, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

Hepatitis C virus infection in dialysis: a continuing problem

B J Pereira1

  • 1Division of Nephrology, New England Medical Center, Tufts University School of Medicine, Boston, Massachusetts 02111, USA.

Artificial Organs
|February 9, 1999
PubMed

Insights

Patients undergoing chronic dialysis face a high risk of hepatitis C virus (HCV) infection. Strategies to reduce HCV transmission and manage liver disease in these vulnerable patients are crucial.

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Nephrology

Background:

  • Patients on chronic dialysis are susceptible to parenterally transmitted hepatitis viruses.
  • Hepatitis C virus (HCV) is a significant cause of liver disease in this population.
  • Biochemical liver function abnormalities affect 10-44% of hemodialysis patients.

Purpose of the Study:

  • To highlight the risk of hepatitis C virus (HCV) transmission in chronic dialysis patients.
  • To discuss the clinical course and consequences of HCV infection in this demographic.
  • To address the ongoing debate on strategies for reducing HCV transmission and managing liver disease.

Main Methods:

  • Review of existing literature on viral hepatitis in dialysis patients.
  • Analysis of the impact of hepatitis C virus (HCV) discovery on understanding non-A, non-B hepatitis.
  • Discussion of current strategies for HCV prevention and management in hemodialysis settings.

Main Results:

  • Hepatitis C virus (HCV) is now recognized as the primary cause of non-A, non-B hepatitis in dialysis patients.
  • Dialysis patients are at increased risk due to blood product transfusions and nosocomial transmission.
  • Effective strategies are needed to curb HCV spread and mitigate liver disease impact.

Conclusions:

  • Reducing hepatitis C virus (HCV) transmission is a priority in hemodialysis units.
  • Management of liver disease in infected dialysis patients requires focused attention.
  • Further research and implementation of preventive measures are essential for patient well-being.

More Related Videos

"Liver-on-a-Chip" Cultures of Primary Hepatocytes and Kupffer Cells for Hepatitis B Virus Infection10:25

"Liver-on-a-Chip" Cultures of Primary Hepatocytes and Kupffer Cells for Hepatitis B Virus Infection

Published on: February 19, 2019

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks10:28

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

Published on: June 26, 2020

Related Concept Videos

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy01:26

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in critically...
Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this measurement...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...